NSMC Intern Elba Medina creates a crisp VA for the PRAECIS trial.
Also, we have some bonus VAs this time created for NephMadness by our VA editor Divya Bajpai!
Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies,
in this edition: Fish Oil, GBD, Flozination meta-analysis, CHW intervention in Hispanic/Latino patients, and much more
in this edition: Atacicept in IgAN; Albuminuria as a surrogate outcome, Renal Remission and additional CONFIDENCE analysis
This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy
NSMC Intern Elba Medina creates a crisp VA for the PRAECIS trial.
Also, we have some bonus VAs this time created for NephMadness by our VA editor Divya Bajpai!
Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial (Kitt, JAMA 2023)
Any reduction in maternal kidney mass makes a difference during pregnancy in gestational and fetal outcome. (Kidney International 2024)
After CHIP we discussed CHAP. In case you missed it, we have you covered here:
Welcome to #TenTweetNephJC
— Nephrology Jrnl Club (@NephJC) June 1, 2022
✳️ Last week's #NephJC in 10 tweets ✳️
Did you miss the latest CHAPter of #NephJC? Join us as we catch you up on the Chronic Hypertension in Pregnancy trial -- the CHAP chat!https://t.co/zdjwgONpt1 pic.twitter.com/4RK5HKulC6